Gene× abstinence effects on drug cue reactivity in addiction: multimodal evidence
SJ Moeller, MA Parvaz, E Shumay… - Journal of …, 2013 - Soc Neuroscience
Functional polymorphisms in the dopamine transporter gene (DAT1 or SLC6A3) modulate
responsiveness to salient stimuli, such that carriers of one 9R-allele of DAT1 (compared with …
responsiveness to salient stimuli, such that carriers of one 9R-allele of DAT1 (compared with …
Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders
AJ Brewer III, DA Nielsen, CJ Spellicy… - Pharmacogenetics …, 2015 - journals.lww.com
Objective The aim of this study was to identify gene variants of DAT1 (SLC6A3) that
modulate subjective responses to acute cocaine exposure. Methods Non-treatment-seeking …
modulate subjective responses to acute cocaine exposure. Methods Non-treatment-seeking …
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample
C Guindalini, M Howard, K Haddley… - Proceedings of the …, 2006 - National Acad Sciences
The dopamine (DA) transporter DAT1 is a major target bound by cocaine in brain. We
examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat …
examined the influence of functional genetic variants in DAT1 on cocaine addiction. Repeat …
[HTML][HTML] Imaging genetics and the neurobiological basis of individual differences in vulnerability to addiction
BACKGROUND: Addictive disorders are heritable, but the search for candidate functional
polymorphisms playing an etiological role in addiction is hindered by complexity of the …
polymorphisms playing an etiological role in addiction is hindered by complexity of the …
Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence
Rationale Alcohol dependence is characterized by the development of tolerance, withdrawal
symptoms, and craving for alcohol. Chronic alcohol consumption causes neuroadaptive …
symptoms, and craving for alcohol. Chronic alcohol consumption causes neuroadaptive …
Pharmacogenetic Role of Dopamine Transporter (SLC6A3) Variation on Response to Disulfiram Treatment for Cocaine Addiction
JP Kampangkaew, CJ Spellicy… - … American journal on …, 2019 - Wiley Online Library
Background and Objectives Disulfiram has been beneficial in treating cocaine addiction in
several studies. Patients with two SLC6A3 (DAT1) rs28363170 10‐repeat alleles who have …
several studies. Patients with two SLC6A3 (DAT1) rs28363170 10‐repeat alleles who have …
Amphetamine reverses escalated cocaine intake via restoration of dopamine transporter conformation
Cocaine abuse disrupts dopamine system function, and reduces cocaine inhibition of the
dopamine transporter (DAT), which results in tolerance. Although tolerance is a hallmark of …
dopamine transporter (DAT), which results in tolerance. Although tolerance is a hallmark of …
[HTML][HTML] Genotype and ancestry modulate brain's DAT availability in healthy humans
E Shumay, J Chen, JS Fowler, ND Volkow - PloS one, 2011 - journals.plos.org
The dopamine transporter (DAT) is a principal regulator of dopaminergic neurotransmission
and its gene (the SLC6A3) is a strong biological candidate gene for various behavioral-and …
and its gene (the SLC6A3) is a strong biological candidate gene for various behavioral-and …
[HTML][HTML] Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction
D Sullivan, JK Pinsonneault, AC Papp, H Zhu… - Translational …, 2013 - nature.com
Epistatic gene–gene interactions could contribute to the heritability of complex multigenic
disorders, but few examples have been reported. Here, we focus on the role of aberrant …
disorders, but few examples have been reported. Here, we focus on the role of aberrant …
[HTML][HTML] Dopamine transporter gene associated with diminished subjective response to amphetamine
DC Lott, SJ Kim, EH Cook, H de Wit - Neuropsychopharmacology, 2005 - nature.com
Individual variability in responses to stimulant drugs may influence risk of stimulant abuse
and treatment response. However, the genetic determinants of this variability have yet to be …
and treatment response. However, the genetic determinants of this variability have yet to be …